Detalhe da pesquisa
1.
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis.
Radiol Med;
128(11): 1423-1428, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37597125
2.
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736).
Cancers (Basel);
15(3)2023 Feb 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36765948
3.
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy.
J Geriatr Oncol;
14(1): 101411, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36496347
4.
Choline PET/CT in recurrent prostate cancer.
Front Oncol;
13: 1079808, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37025599
5.
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275).
Med Oncol;
39(8): 119, 2022 Jun 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35687207